Two cystic fibrosis drugs which have been described as “life-changing” by campaigners have been rejected for use by the NHS in Scotland.
The Scottish Medicines Consortium said there were uncertainties about the long-term health benefits of Orkambi and Symkevi in relation to their costs.
Both drugs are manufactured by Vertex.
It said it was working with the Scottish government to find a solution to allow broad access for eligible patients as a matter of urgency.